Inhibition of Src with AZD0530 Reveals the Src-Focal Adhesion Kinase Complex as a Novel Therapeutic Target in Papillary and Anaplastic Thyroid Cancers

Παρόμοια τεκμήρια

• Inhibition of Src with AZD0530 Reveals the Src-Focal Adhesion Kinase Complex as a Novel Therapeutic Target in Papillary and Anaplastic Thyroid Cancer
  ανά: Schweppe, Rebecca E., κ.ά.
  Έκδοση: (2009)
• Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530
  ανά: Green, Tim P., κ.ά.
  Έκδοση: (2009)
• Phase II Study of the Src Kinase Inhibitor Saracatinib (AZD0530) in Metastatic Melanoma
  ανά: Gangadhar, Tara C., κ.ά.
  Έκδοση: (2012)
• Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530
  ανά: Chang, Y-M, κ.ά.
  Έκδοση: (2008)
• The effect of the dual Src/Abl kinase inhibitor AZD0530 on Philadelphia positive leukaemia cell lines
  ανά: Gwanmesia, Patricia Mambou, κ.ά.
  Έκδοση: (2009)